The estimated Net Worth of Kevin D Cordell is at least $6.63 Milhão dollars as of 17 August 2020. Mr. Cordell owns over 3,470 units of Wright Medical NV stock worth over $3,689,998 and over the last 9 years he sold WMGI stock worth over $830,145. In addition, he makes $2,105,000 as Executive Vice President e Chief Global Commercial Officer at Wright Medical NV.
Kevin has made over 15 trades of the Wright Medical NV stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 3,470 units of WMGI stock worth $104,621 on 17 August 2020.
The largest trade he's ever made was exercising 141,500 units of Wright Medical NV stock on 21 November 2019 worth over $3,103,095. On average, Kevin trades about 6,407 units every 66 days since 2015. As of 17 August 2020 he still owns at least 123,082 units of Wright Medical NV stock.
You can see the complete history of Mr. Cordell stock trades at the bottom of the page.
Kevin D. Cordell serves as Executive Vice President, Chief Global Commercial Officer of the Company. VPrior to such position, he served as President, U.S. June 2016 to December 2018. From October 2015 to June 2016, he served as our President, Lower Extremities and Biologics. Mr. Cordell served as President, U.S. Extremities of Wright Medical Group, Inc. from September 2014 to October 2015. Prior to joining legacy Wright, Mr. Cordell served as Vice President of Sales for the GI Solutions business at Covidien plc, a global healthcare products company, from May 2012 to September 2014. While at Covidien, he served as Vice President of Sales and Global Marketing for its Peripheral Vascular business from July 2010 to May 2012. He joined Covidien in July 2010 through the acquisition of ev3 Inc., a global endovascular device company, where he served as Vice President of U.S. Sales from January 2009 to July 2010. Prior to ev3, Mr. Cordell served as Vice President, Global Sales of FoxHollow Technologies, Inc. from March 2007 until it was acquired by ev3 in October 2007. Earlier in his career, Mr. Cordell held various positions of increasing responsibility for Johnson & Johnson’s Cordis Cardiology and Centocor companies. Mr. Cordell currently serves on the University of Oklahoma Healthcare Board. Mr. Cordell previously served on the board of directors of TissueGen, Inc., a privately-held developer of biodegradable polymer technology for implantable drug delivery.
As the Executive Vice President e Chief Global Commercial Officer of Wright Medical NV, the total compensation of Kevin Cordell at Wright Medical NV is $2,105,000. There are 3 executives at Wright Medical NV getting paid more, with Robert Palmisano having the highest compensation of $7,309,180.
Kevin Cordell is 54, he's been the Executive Vice President e Chief Global Commercial Officer of Wright Medical NV since 2019. There are 14 older and 9 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
Kevin's mailing address filed with the SEC is , 1023 CHERRY ROAD, MEMPHIS, TN, 38117.
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman, eHoldings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Wright Medical NV executives and other stock owners filed with the SEC include: